Cargando…

Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series

OBJECTIVE: To investigate the effect of convalescent plasma therapy (CPT) on clinical courses of B-cell-sufficient and B-cell-depleted patients with life-threatening COVID-19. PATIENTS AND METHODS: In this case series, we retrospectively analysed clinical, laboratory and cardiopulmonary parameters o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erber, Johanna, Wiessner, Johannes R., Huberle, Christina, Schneider, Jochen, Mijočević, Hrvoje, von Bomhard, Doris, Luppa, Peter, Schmid, Roland M., Rasch, Sebastian, Lahmer, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447834/ https://www.ncbi.nlm.nih.gov/pubmed/34548246 http://dx.doi.org/10.1016/j.transci.2021.103278

Ejemplares similares

Longitudinal Assessment of Health and Quality of Life of COVID-19 Patients Requiring Intensive Care—An Observational Study
por: Erber, Johanna, et al.
Publicado: (2021)

SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment
por: Lahmer, Tobias, et al.
Publicado: (2022)

Extracorporeal carbon dioxide removal with the Advanced Organ Support system in critically ill COVID‐19 patients
por: Allescher, Julia, et al.
Publicado: (2021)

Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
por: Hueso, Thomas, et al.
Publicado: (2020)

Accuracy of hemodynamic parameters derived by GE E-PiCCO in comparison with PiCCO® in patients admitted to the intensive care unit
por: Putko, Katarzyna, et al.
Publicado: (2023)

B-Lines Scores Derived From Lung Ultrasound Provide Accurate Prediction of Extravascular Lung Water Index: An Observational Study in Critically Ill Patients
por: Mayr, Ulrich, et al.
Publicado: (2020)

Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products
por: Kenig, Ariel, et al.
Publicado: (2021)

Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell–Depleted Patients
por: Gharbharan, Arvind, et al.
Publicado: (2021)

Efficacy of Convalescent Plasma to Treat Long-Standing COVID-19 in Patients with B-Cell Depletion
por: Tomisti, Luca, et al.
Publicado: (2023)

Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS
por: Rasch, Sebastian, et al.
Publicado: (2021)

Successful treatment of COVID‐19 infection with convalescent plasma in B‐cell‐depleted patients may promote cellular immunity
por: Kremer, Andreas E., et al.
Publicado: (2021)

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma
por: Gaitzsch, Erik, et al.
Publicado: (2021)

Blinatumomab/convalescent-anti-SARS-CoV-2-plasma: B-cell depletion and off label use: case report
Publicado: (2021)

Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents
por: Koerber, Nina, et al.
Publicado: (2022)

Risk factors for Herpes simplex virus (HSV) and Cytomegalovirus (CMV) infections in critically-ill COVID-19 patients
por: Fuest, Kristina E., et al.
Publicado: (2022)

SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic
por: Schneider, Jochen, et al.
Publicado: (2021)

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
por: Magyari, Ferenc, et al.
Publicado: (2022)

B cell depletion in autoimmune disease
por: Gorman, Claire, et al.
Publicado: (2003)

B cells: deplete, repopulate, vaccinate
por: Phillips, Robert
Publicado: (2022)

First description of spontaneous fungal peritonitis caused by Fusarium solani in a critically ill patient with liver cirrhosis
por: Mayr, U., et al.
Publicado: (2017)

Penetration of Isavuconazole in Ascites Fluid of Critically Ill Patients
por: Lahmer, Tobias, et al.
Publicado: (2021)

Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates
por: Ioannou, Petros, et al.
Publicado: (2023)

Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients
por: Deschler, Sebastian, et al.
Publicado: (2021)

Influence of a Structured Microbiological Endotracheal Monitoring Program on the Outcome of Critically Ill COVID-19 Patients: An Observational Study
por: Dibos, Miriam, et al.
Publicado: (2023)

Alterations in T and B cell function persist in convalescent COVID-19 patients
por: Shuwa, Halima A., et al.
Publicado: (2021)

Obinutuzumab: B-cell depletion: case report
Publicado: (2021)

Rituximab: B cell depletion: case report
Publicado: (2021)

PB2276: EARLY ADMINISTRATION OF REMDESIVIR PLUS CONVALESCENT PLASMA THERAPY IS EFFECTIVE TO TREAT COVID-19 PNEUMONIA IN B-CELL DEPLETED PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Pinczes, L. I., et al.
Publicado: (2022)

Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis
por: Lahmer, Tobias, et al.
Publicado: (2016)

Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
por: Lahmer, T., et al.
Publicado: (2020)

High lipasemia is frequent in Covid-19 associated acute respiratory distress syndrome
por: Rasch, Sebastian, et al.
Publicado: (2021)

EASIX Is an Accurate and Easily Available Prognostic Score in Critically Ill Patients with Advanced Liver Disease
por: Schult, David, et al.
Publicado: (2023)

Tailoring B cell depletion therapy in MS according to memory B cell monitoring
por: Novi, Giovanni, et al.
Publicado: (2020)

Development of Accessory Cells in B-Cell Compartments Is Retarted in B-Cell-Depleted Fetal Sheep
por: Press, Charles Mcl., et al.
Publicado: (1998)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

B cell depletion reduces the development of atherosclerosis in mice
por: Ait-Oufella, Hafid, et al.
Publicado: (2010)

B Cell Depletion: Rituximab in Glomerular Disease and Transplantation
por: Marinaki, S., et al.
Publicado: (2013)

CTLA-4–B7 Interaction Is Sufficient to Costimulate T Cell Clonal Expansion
por: Wu, Yan, et al.
Publicado: (1997)

Convalescent-anti-sars-cov-2-plasma/dexamethasone/rituximab: Depletion of B-lymphocytes, lack of efficacy and off label treatment: case report
Publicado: (2022)

Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis
por: Möller, Burkhard, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qjmsiv386en5ob7pk312k1jj0b